Hiroshi Mabuchi

16.6k citations

390 papers · 13.0k indexed · 1 hit paper · h-index 60

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
Cardiology and Cardiovascular Medicine top 0.5%
- Lipid metabolism and disorders
- Cardiac electrophysiology and arrhythmias
- Cardiomyopathy and Myosin Studies

Papers in

Endocrinology, Diabetes and Metabolism 127
- Diabetes, Cardiovascular Risks, and Lipoproteins 84
- Hormonal Regulation and Hypertension 22
Cardiology and Cardiovascular Medicine 136
- Lipid metabolism and disorders 41
- Cardiomyopathy and Myosin Studies 27
- Cardiovascular Function and Risk Factors 19

Co-authors: Akihiro Inazu Junji Koizumi Atsushi Nohara Masa‐aki Kawashiri Masami Shimizu Junji Kobayashi Susumu Miyamoto Kouji Kajinami
Journals: Atherosclerosis (37 papers)Journal of Atherosclerosis and Thrombosis (31 papers)Circulation Journal (19 papers)Clinica Chimica Acta (14 papers)The American Journal of Cardiology (9 papers)
Partner nations: Japan United States China

In The Last Decade

Hiroshi Mabuchi

379 papers receiving 12.6k citations

Hit Papers

align trajectories log scale

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation 1990 · 687 citations

Peers

Countries citing papers authored by Hiroshi Mabuchi

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Mabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Mabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Mabuchi more than expected).

Fields of papers citing papers by Hiroshi Mabuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Mabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Mabuchi. The network helps show where Hiroshi Mabuchi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroshi Mabuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroshi Mabuchi Line = papers co-authored together Hiroshi Mabuchi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation Atherosclerosis ·Hiroshi Mabuchi, Atsushi Nohara, Tohru Noguchi, Junji Kobayashi, Masa‐aki Kawashiri, Takeshi Inoue, Mika Mori, Hayato Tada, Chiaki Nakanishi, Kunimasa Yagi, Masakazu Yamagishi, Kousei Ueda, Tadayoshi Takegoshi, Susumu Miyamoto, Akihiro Inazu, Junji Koizumi	2014	64
2	A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma Journal of Lipid Research ·Shigeyuki Imamura, Jun Kobayashi, Katsuyuki Nakajima, Shin‐ichi Sakasegawa, Atsushi Nohara, Tohru Noguchi, Masa‐aki Kawashiri, Akihiro Inazu, S S Deeb, Hiroshi Mabuchi, John D. Brunzell	2008	29
3	Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT) Hypertension Research ·Kazuaki Shimamoto, Toru Kita, Hiroshi Mabuchi, Masunori Matsuzaki, Yūji Matsuzawa, Noriaki Nakaya, Shinichi Oikawa, Yasushi Saitō, Junichi Sasaki, Hiroshige Itakura	2007	8
4	Raloxifene promotes adipocyte differentiation of 3T3-L1 cells European Journal of Pharmacology ·Yuko Murase, Junji Kobayashi, Atsushi Nohara, Akimichi Asano, 张福瑞, Kaoru Suzuki, Hiroshi Sato, Hiroshi Mabuchi	2006	23
5	Clinical Features of Hypertrophic Cardiomyopathy Caused by a Novel Val85Leu Missense Mutation in the Cardiac Troponin T Gene(Cardiomyopathy, Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) Japanese Circulation Journal-english Edition ·Noboru Fujino, Masami Shimizu, Hidekazu Ino, Tetsuo Konno, Hiromasa Katoh, Sebastián Martín Martín, Sumio Mizuno, D. J. Witte, Hiroshi Mabuchi	2005	1
6	Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients Journal of Atherosclerosis and Thrombosis ·Hiroshi Mabuchi, Toshinori Higashikata, Masa‐aki Kawashiri, Shoji Katsuda, Mihoko Mizuno, Atsushi Nohara, Akihiro Inazu, Junji Koizumi, Junji Kobayashi	2005	97
7	PJ-596 Exercise-induced Systolic Dysfunction in Patients with Non-obstructive Hypertrophic Cardiomyopathy and Mutations in the Cardiac Troponin Genes(Cardiomyopathy, Clinical 7 (M) : PJ100)(Poster Session (Japanese)) Japanese Circulation Journal-english Edition ·Kenji Sakata, Masami Shimizu, Hidekazu Ino, Masato Yamaguchi, Hidenobu Terai, Noboru Fujino, Mitsuru Nagata, Masaru Inoue, Junichi Taki, Hiroshi Mabuchi	2004	0
8	Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. PubMed ·Hidenobu Terai, Masami Shimizu, Hidekazu Ino, Masato Yamaguchi, Katsuharu Uchiyama, Kotaro Oe, Kenichi Nakajima, Junichi Taki, Masaya Kawano, Hiroshi Mabuchi	2003	19
9	A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients Journal of the American College of Cardiology ·Tetsuo Konno, Masami Shimizu, Hidekazu Ino, Laila Badria, Masato Yamaguchi, Hidenobu Terai, Kenshi Hayashi, Tomohito Mabuchi, Zhong-Li, Kenji Sakata, Muhammad Rusydi, Masaru Inoue, Tomoya Kaneda, Hiroshi Mabuchi	2003	56
10	Increased matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction Japanese Circulation Journal-english Edition ·Yoshihiro Noji, Masami Shimizu, Hidekazu Ino, Toshinori Higashikata, Masato Yamaguchi, Atsushi Nohara, Hiroshi Mabuchi	2002	3
11	Kanzo ·誠三富, Ольга Вікторівна Курінська, Vadim Kolesnikov, 貴之岩渕, 吴明建, Hiroshi Mabuchi	2002	1
12	Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation American Heart Journal ·Masami Shimizu, Hidekazu Ino, Kazuyasu Okeie, Masato Yamaguchi, Kenshi Hayashi, Mitsuru Nagata, Hideki Itoh, Taku Iwaki, Kotaro Oe, Tetsuo Konno, Hiroshi Mabuchi	2002	10
13	Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III Journal of Human Genetics ·Julie Jouvion, Minoru Okubo, Nelson L.S. Tang, Joannie Hui, Ka‐Fai To, Nick Magnussen, Toshihide Okada, Hiroshi Mabuchi, Toshio Murase	2002	18
14	Sodium-Induced Cardiac Aldosterone Synthesis Causes Cardiac Hypertrophy Endocrinology ·Yoshiyu Takeda, Takashi Yoneda, Masashi Demura, Isamu Miyamori, Hiroshi Mabuchi	2000	112
15	[Hyperlipidemia and arteriosclerosis]. PubMed ·Hiroshi Mabuchi	1998	6
16	Severe Gastrointestinal Complications of Dialysis-Related Amyloidosis in Two Patients on Long-Term Hemodialysis American Journal of Nephrology ·Hideo Araki, Т. Б. Таргашина, Kunio Oda, Ichiro Koni, Hiroshi Mabuchi, Yuji Mizukami, Akitaka Nonomura	1996	25
17	Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. Journal of Clinical Investigation ·Akihiro Inazu, Xian‐Cheng Jiang, Tatsuo Haraki, Kunimasa Yagi, Songsong Li, Jun‐ichi Koizumi, Hiroshi Mabuchi, R Takeda, Kazuhide Takata, Yuri Moriyama	1994	198
18	-0954-ABDOMINAL ARTIC ANEURYSM OF FAMILIAL HYPERCHOLESTEROLEMIA : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY Japanese Circulation Journal-english Edition ·Yoshihito Kita, Masami Shimizu, Norihiko Sugihara, Kuniyoshi Shimizu, 須崎勝正, Andrea F. Zuur, A Odumosu, Hiroshi Mabuchi, Ryoyu Takeda	1990	1
19	Diagnostic Criteria for Familial Hypercholesterolemia in Japan Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Hiroshi Mabuchi, Ryozo Tatami, Kosei Ueda, Ryosei Ueda, Toshihiro Haba, Tomio KAMETANI, Seigo Ito, Junji Koizumi, Susumu Miyamoto, 善之天野, Ryoyu Takeda, Tadayoshi Takegoshi	1977	3
20	Studies on the Diagnosis of Type III Hyperlipoproteinemia A suggestion of chemical criteria based on VLDL-cholesterol and VLDL-cholesterol/VLDL-triglyceride Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Hiroshi Mabuchi, Kosei Ueda, Ryosei Ueda, Ryozo Tatami, Toshihiro Haba, Tomio KAMETANI, Seigo Ito, Junji Koizumi, 善之天野, Susumu Miyamoto, Ryoyu Takeda	1977	4

About Hiroshi Mabuchi

Hiroshi Mabuchi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Cancer Research and Rheumatology, having authored 390 papers that have together received 13.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (159 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (84 papers), Cancer, Lipids, and Metabolism (63 papers), Cholesterol and Lipid Metabolism (41 papers), Lipid metabolism and disorders (41 papers), Cardiomyopathy and Myosin Studies (27 papers), Hormonal Regulation and Hypertension (22 papers) and Cardiovascular Function and Risk Factors (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.5k citations), Cardiology and Cardiovascular Medicine (4.1k citations), Surgery (6.7k citations), Cancer Research (1.9k citations) and Biochemistry (315 citations). Hiroshi Mabuchi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Akihiro Inazu, Junji Koizumi, Atsushi Nohara, Masa‐aki Kawashiri, Masami Shimizu, Junji Kobayashi, Susumu Miyamoto, Kouji Kajinami, Yoshiyu Takeda and Masakazu Yamagishi. Their work appears in journals such as Atherosclerosis, Journal of Atherosclerosis and Thrombosis, Circulation Journal, Clinica Chimica Acta and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact